The upregulation of TLR4 in HCC cells activates the STAT3 signalling pathway which promotes tumour progression, aggressiveness, and chemoresistance, thereby conferring poor patient prognosis [145,146,147]. The gene discussed is TLR4; the disease is hepatocellular carcinoma.